Professor, Internal Medicine, University of Missouri, Columbia School of Medicine
Cardiology
Dr. William P. Fay, MD
|
|
Give Review
Dr. William P. Fay works in the field of Cardiology. He attended University of Illinois College of Medicine. He received 1 awards: "Fellow (FACC)". William P. Fay, MD has written publications. He has 31 publications published with PubMed. The lastest paper is: 'Plasminogen Activator Inhibitor-1 Inhibits Angiogenic Signaling by Uncoupling Vascular Endothelial Growth Factor Receptor-2-V3 Integrin Cross Talk.'
Publications
- Plasminogen Activator Inhibitor-1 Inhibits Angiogenic Signaling by Uncoupling Vascular Endothelial Growth Factor Receptor-2-αVβ3 Integrin Cross Talk.
- C-reactive protein induces expression of tissue factor and plasminogen activator inhibitor-1 and promotes fibrin accumulation in vein grafts.
- ANTECEDENT HYDROGEN SULFIDE ELICITS AN ANTI-INFLAMMATORY PHENOTYPE IN POSTISCHEMIC MURINE SMALL INTESTINE: ROLE OF HEME OXYGENASE-1.
- Intravital fluorescence microscopy improves thrombosis phenotype scoring in mice.
- Thrombosis, Physical Activity, and Acute Coronary Syndromes.
- Multifaceted Role of Plasminogen Activator Inhibitor-1 in Regulating Early Remodeling of Vein Bypass Grafts.
- Endothelial-derived tissue factor pathway inhibitor regulates arterial thrombosis but is not required for development or hemostasis.
- Recombinant plasminogen activator inhibitor-1 inhibits intimal hyperplasia.
- C-reactive protein enhances tissue factor expression by vascular smooth muscle cells: mechanisms and in vivo significance.
- Double knockouts reveal that protein tyrosine phosphatase 1B is a physiological target of calpain-1 in platelets.
- Vascular functions of the plasminogen activation system.
- Atherosclerosis in mice is not affected by a reduction in tissue factor expression.
- MT1-matrix metalloproteinase directs arterial wall invasion and neointima formation by vascular smooth muscle cells.
- Macrovascular thrombosis is driven by tissue factor derived primarily from the blood vessel wall.
- Factor VLeiden inhibits fibrinolysis in vivo.
- Antidote-mediated control of an anticoagulant aptamer in vivo.
- Plasminogen is a critical host pathogenicity factor for group A streptococcal infection.
- Induction of heme oxygenase-1 expression inhibits platelet-dependent thrombosis.
- Plasminogen activator inhibitor 1, fibrin, and the vascular response to injury.
- Plasminogen enhances virulence of group A streptococci by streptokinase-dependent and streptokinase-independent mechanisms.
- Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice.
- Structure-function analysis of the streptokinase amino terminus (residues 1-59).
- Chronic iron administration increases vascular oxidative stress and accelerates arterial thrombosis.
- Myocardial proinflammatory cytokine expression and left ventricular remodeling in patients with Chronic mitral regurgitation.
- Prolonged low-dose thrombolytic therapy: a novel adjunctive strategy in the management of an infected right Atrial thrombus.
- Endogenous vitronectin and plasminogen activator inhibitor-1 promote neointima formation in murine Carotid arteries.
- Do clinically relevant circulating concentrations of radiographic contrast agents inhibit platelet-dependent arterial thrombosis?
- Thrombin-activatable fibrinolysis inhibitor (TAFI) deficiency is compatible with murine life.
- Acute isolated right ventricular myocardial infarction masquerading as Acute anterior myocardial infarction.
- Almost everyone over 50 should be put on a statin to reduce the risk of cardiovascular Disease: A contrarian view.
Schools
University of Illinois At Chicago College of Medicine
University Mich Hosps
Mayo Clinic Rochester
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Aneurysm and Dissection of Heart
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Dissection
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Fellow (FACC)
Education
-
Mayo School of Graduate Medical Education -
University of Michigan Hospitals and Health Centers -
University of Illinois College of Medicine
Drug Facts
| NPI NUMBER | 1467404814 | |
| NPPES Provider LastName | FAY | |
| NPPES Provider FirstName | WILLIAM | |
| NPPES Provider ZIPCode | 652120001 | |
| NPPES Provider State | MO | |
| Specialty Description | Cardiology | |
| Total Claim Count | 2407.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1467404814 |
| Last Name Of The Provider | FAY |
| First Name Of The Provider | WILLIAM |
| View All |
Similar Doctors
|
|
Dr. Poonam Velagapudi, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donald W. Dickhaus, MD |
|
|
Dr. Dan L. Pierce, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sanjeev D. Ravipudi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Annamalai Senthilkumar, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary L. Dohrmann, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Greg Flaker, MD
This Doctor is OpenDoctor Recommended.
|